Prevalence of SDB in lung transplant recipients

J. Verbraecken

Source: Breathe 2010; 6: 274
Journal Issue: March

PDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
J. Verbraecken. Prevalence of SDB in lung transplant recipients. Breathe 2010; 6: 274

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Prevalence and outcomes of diabetes in lung transplant recipients: the portuguese experience
Source: Virtual Congress 2020 – Clinical management of lung transplant recipients
Year: 2020


CMV management in lung transplant recipients
Source: School Course 2012 - Lung Transplantation
Year: 2012


Electronic nose for detecting chronic lung allograft dysfunction in lung transplant recipients
Source: Virtual Congress 2021 – Optimising outcomes of lung transplantation: how to move forward?
Year: 2021



Chronic respiratory complications in paediatric heart transplant recipients
Source: Eur Respir J 2006; 28: Suppl. 50, 311s
Year: 2006

Breath VOC patterns of lung transplant recipients with and without chronic lung allograft dysfunction (CLAD)
Source: International Congress 2017 – Chronic airway disease: markers of disease impact
Year: 2017

Chronic lung allograft disease: prevalence and FEV1 decline in a Brazilian lung transplant cohort.
Source: International Congress 2017 – Lung transplant outcomes
Year: 2017


Sleep quality and sleep-disordered breathing in lung transplant recipients
Source: Annual Congress 2012 - Lung transplantation: studies in candidates and recipients
Year: 2012


Pulmonary complications in heart transplant recipients
Source: Eur Respir J 2004; 24: Suppl. 48, 181s
Year: 2004

Long-term follow-up of lung transplant recipients with obstructive airway complications
Source: Annual Congress 2008 - Donor organs and complications after lung transplantation
Year: 2008

Prevalence and echocardiographic screening for pulmonary hypertension in liver transplantation recipients
Source: International Congress 2019 – Pulmonary hypertension: clinical
Year: 2019


Pulmonary complications in renal transplant recipients
Source: Annual Congress 2009 - Complications of respiratory infections: impact of comorbidities and infections caused by Aspergillus
Year: 2009

Aspergillus infections in lung transplant recipients. Risk factors and outcome
Source: Eur Respir J 2004; 24: Suppl. 48, 178s
Year: 2004

Fatigue and functional capacity in kidney transplant recipients before and after transplant.
Source: International Congress 2017 – Assessing functional outcomes in respiratory physiotherapy
Year: 2017


Prevalence of pre-transplant anti-HLA antibodies and their impact on outcomes in lung transplant recipients
Source: International Congress 2016 – Long-term outcomes of lung transplantation
Year: 2016

Long-term kinetics of CD19+CD24highCD38highBreg cells in lung transplant recipients
Source: International Congress 2016 – Lung allograft dysfunction: insights into inflammatory/immune mechanisms
Year: 2016


Pulmonary function in patients with end-stage renal disease and renal transplant recipients
Source: Eur Respir J 2004; 24: Suppl. 48, 56s
Year: 2004

Assessment of the restrictive allograft syndrome in patients after lung transplantation
Source: Annual Congress 2012 - Lung transplantation: studies in candidates and recipients
Year: 2012

Patterns of RSV-infection in adult lung transplant patients during epidemic occurrence of RSV-infections
Source: Eur Respir J 2003; 22: Suppl. 45, 326s
Year: 2003

Respiratory infections in heart transplant patients
Source: International Congress 2016 – Long-term outcomes of lung transplantation
Year: 2016


Covid 19 in a lung transplant population
Source: Virtual Congress 2021 – Challenging problems in lung transplantation
Year: 2021